J.H. Verheijen
- Cancer Research
- Rheumatology top 10%
- Molecular Biology
- Hematology top 10%
- Oncology
- Co-authors
- H. K. RondayW.H. van der LaanFC BreedveldJ.M. TeKoppeleT. HuizingaPaul H.A. QuaxL.G.M. HuismanJos Grimbergen
- Topics
- Protease and Inhibitor Mechanisms (10 papers)Rheumatoid Arthritis Research and Therapies (7 papers)Signaling Pathways in Disease (3 papers)
- Partner nations
- NetherlandsSwitzerlandGermany
In The Last Decade
J.H. Verheijen
16 papers receiving 360 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 154
- Rheumatology 133
- Molecular Biology 106
- Hematology 87
- Oncology 76
Countries citing papers authored by J.H. Verheijen
This map shows the geographic impact of J.H. Verheijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.H. Verheijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.H. Verheijen more than expected).
Fields of papers citing papers by J.H. Verheijen
This network shows the impact of papers produced by J.H. Verheijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.H. Verheijen. The network helps show where J.H. Verheijen may publish in the future.
Co-authorship network of co-authors of J.H. Verheijen
This figure shows the co-authorship network connecting the top 25 collaborators of J.H. Verheijen. A scholar is included among the top collaborators of J.H. Verheijen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.H. Verheijen. J.H. Verheijen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 88 | |
| 2 | No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study. | 4 |
| 3 | 3 | |
| 4 | 73 | |
| 5 | Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial. | 20 |
| 6 | 1 | |
| 7 | Lack of effect of doxyxyxline on disease activity and pyridinoline excretion rates in rheumatoid arthritis : a double-blind placebo-controlled study: abstract | 1 |
| 8 | 42 | |
| 9 | 8 | |
| 10 | 18 | |
| 11 | Local treatment of venous ulcers with tissue type plasminogen activator containing ointment. | 5 |
| 12 | 67 | |
| 13 | 8 | |
| 14 | 4 | |
| 15 | 1 | |
| 16 | 28 |
About J.H. Verheijen
J.H. Verheijen is a scholar working on Cancer Research, Rheumatology and Hematology, having authored 16 papers that have together received 371 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (10 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Signaling Pathways in Disease (3 papers). The work is most often cited by research in Cancer Research (154 citations), Immunology and Allergy (61 citations) and Rheumatology (133 citations). J.H. Verheijen has collaborated with scholars based in Netherlands, Switzerland and Germany. Frequent co-authors include H. K. Ronday, W.H. van der Laan, FC Breedveld, J.M. TeKoppele, T. Huizinga, Paul H.A. Quax, L.G.M. Huisman, Jos Grimbergen, F. C. Breedveld and Thomas Pap. Their work appears in journals such as Annals of the Rheumatic Diseases, Carcinogenesis and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.